Xencor Inc

XNCR chart

Xencor Inc news

• Xencor (NASDAQ:XNCR) Hits New 52-Week High - Should You Buy?

  MarketBeat · Nov 10, 11:33 AM EST

• Xencor (XNCR) Shares Rise on Early Phase 1b Trial Data for Rheum

  GuruFocus · Nov 9, 9:26 AM EST

• Xencor reports early trial data for autoimmune therapies By Investing.com

  Investing.com India · Nov 9, 8:30 AM EST

• Xencor reports early plamotamab data in rheumatoid arthritis trial

  StreetInsider · Nov 9, 8:08 AM EST

• Xencor Presents Initial Plamotamab Data in Rheumatoid Arthritis at ACR Convergence 2026 and Updates Progress in First-in-Human Study of XmAb657

  Yahoo Finance · Nov 9, 8:01 AM EST

• Wall Street Zen Upgrades Xencor (NASDAQ:XNCR) to Buy

  MarketBeat · Nov 7, 4:30 AM EST

• Show Me The Money: Xencor (XNCR) Delivers Triple-Digit Gains, With XENITH-UC Poised For The Next Act

  RTTNews · Nov 6, 11:35 PM EST

• Xencor, Inc. (XNCR) Stock Price, News, Quote & History

  Yahoo! Finance Canada · Nov 6, 12:51 PM EST

• A passive holder reports 9.88 million Xencor (XNCR) shares in an ownership amendment.

  Stock Titan · Nov 6, 8:44 AM EST

• Xencor (XNCR) Stock Could Be Overvalued On Q3 Earnings Beat

  Simply Wall St · Nov 6, 7:29 AM EST

• Biotech Earnings: Who Won, Who Lost And Who Pulled Off A 'Historic' Launch?

  Yahoo Finance · Nov 5, 4:22 PM EST

• Xencor (NASDAQ:XNCR) Now Covered by Cantor Fitzgerald

  MarketBeat · Nov 5, 8:12 AM EST

Xencor Inc key financials

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 10-Q10-Q2026-11-04
• 8-K8-K2026-11-04
• 8-KCURRENT REPORT2026-10-26
• 10-Q10-Q2026-08-05
• 8-K8-K2026-08-05
• 8-K8-K2026-07-29
• 8-K8-K2026-06-18
• 10-Q10-Q2026-05-06
• 8-K8-K2026-05-06
• 8-K8-K2026-05-05
• DEF 14ADEF 14A2026-04-27
• 8-K8-K2026-04-27

About Xencor Inc

Ticker

XNCR (Nasdaq)

Industry

Pharmaceutical Preparations

Headquarters

Pasadena, CA

Incorporated in

DE

Fiscal year end

December 31

SEC CIK

1326732

Frequently asked questions